Transcript Diphtheria: Clinical Manifestation& Management
พ .
ญ . จริยา แสงสัจจา สถาบันบ าราศนราดูร ๘ ตุลาคม ๒๕๕๕
Acute toxicoinfection
by Corynebacterium caused diphtheria Exclusively inhabitant of human mucous membrane and skin
Corynebacterium diphtheriae
Pathogenesis& pathology
local inflammation, exotoxin , tissue necrosis, grey-brown adherent pseudo-membrane, toxic myocardiopathy, peripheral neuropathy
Transmission
: Droplet and contact: intimate contact with a patient or carrier :Discharge from respiratory tract, eyes and skin lesions :2-6 weeks transmissible without treatment, communicable <4days after appropriate antibiotics
Incubation period :
2-7 days or longer
Low-grade fever: <39 c Serosanguinous, purulent erosive rhinitis Sore throat Upper airway obstruction Dysphagia, Tonsillar membrane formation, extends to uvular, soft palate, pharynx, larynx
Bull-neck
: soft tissue edema and enlarged lymph nodes
Cutaneous diphtheria
: indolent, non progressive Purulent and ulcerative conjunctivitis, vulvovaginitis
Nasal Diphtheria Cutaneous Diphtheria
Streptococcus Sore Throat
Toxic myocardiopathy
:
10-25% of cases, : occurs in the 2nd-3 rd week :Responsible for 50-60% of death :Correlates directly with the extent and severity of exudative local oropharyngeal disease : Tachycardia, prolong PR interval, ST-T change, V-tach, congestive heart failure
Toxic neuropathy :
Acutely or 2-3 weeks after onset :local paralysis of soft palate :Weakness of posterior and facial nerve :Dysphagia, aspiration :
Cranial neuropathy
occur in the 5 th week :
Symmetric polyneuropathy
occur in 10 days to 3 months
Antitoxin Antimicrobial therapy Immunization
Antitoxin
: DAT IV after sensitivity test for reaction, desensitization
Pharyngeal or laryngeal lesions
,48 hr. duration or less, 20,000-40,000 U
Nasopharyngeal lesions
, 40,000-60,000 U
Extensive disease of 3 or more days
duration or diffuse swelling of the neck,80,000-120,000 U of antitoxin Skin lesions only:20,00-40,000U
Antimicrobial therapy
:14 days of erythromycin or penicillin G IV or IM or procaine pen. G IM
Immunization
: 3 doses of diphtheria toxoid,1 st dose at the end of 1 st week of illness
Standard and droplet precautions
for patients and carriers with pharyngeal diphtheria until 2 cultures from both the nose and the throat are negative
Contact precautions
for patient with cutaneous diphtheria until 2 cultures of skin lesions are negative
Care of close contact
:
Surveillance
disease :
Culture
7 days for evidence of for C. diphtheriae :
Antimicrobial prophylaxis
: erythromycin40-50 mg/kg 7days or single dose benzathine pen. G (1.2mU for patient BW>=30kg.,0.6mU for patient BW <30kg.)
Care of close contact
:
Follow up pharyngeal culture
from carrier at 2 weeks after completion of therapy, if culture is positive 10 days course of erythromycin should be given, and follow up culture :
Immunization
of carriers